Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    OK!

    Join Us in Taking A First Look at the Chondrosarcoma Patient Registry

    May 15th, 2023This coming Monday, May 22, we are going to do our first analysis of responses to the survey and take a first look at identifying trends and cause-effect relationships. Your responses to the survey questions are vital to this effort. We want to...

    Read Article

    Chondrosarcoma Foundation’s Third Anniversary Shows Appreciation to It’s Donors, Supporters and Partners

    May 12th, 2023During the past three years many CS Patients, caregivers, family members and friends have supported the Foundation through their donations and fund-raising activities. We received donations from family members in honor of their lost loved ones to...

    Read Article

    Chondrosarcoma Foundation Enters Fourth Year, Marks Progress

    May 11th, 2023BOWIE, Maryland, May 12—The Chondrosarcoma (CS) Foundation will commemorate its third anniversary by continuing to educate the public about this rare bone cancer, advocate for patients fighting the disease and conduct a global natural history...

    Read Article

    Update on Chondrosarcoma Patient Registry

    April 28th, 2023The Chondrosarcoma Foundation in partnership with NORD® launched the Chondrosarcoma Patient Registry on March 1, 2023. The Chondrosarcoma Patient Registry is a platform for patients around the world to strengthen their voices and collectively share...

    Read Article

    Biomarkers of chondrosarcoma

    April 22nd, 2023 Journal of Clinical Pathology J Clin Pathol. 2018 Jul; 71(7): 579–583. Published online 2018 Mar 28. doi: 10.1136/jclinpath-2018-205071 PMCID: PMC6204964 PMID: 29593061 Biomarkers of chondrosarcoma Wonju Jeong1 and Ha-Jeong...

    Read Article

    Update on INBRX Clinical Trials from Inhibrx

    April 11th, 2023The INBRX 109 Clinical Trials will shortly resume recruiting patients for their Phase 2 Clinical Trial treating patients with Conventional Chondrosarcoma with recurrence or metastasis. Listed below is a response from Inhibrx: We have just released...

    Read Article

    Chondrosarcoma Patient Registry at one month

    April 7th, 2023The Chondrosarcoma Foundation in partnership with NORD® launched the Chondrosarcoma Patient Registry on March 1, a little over one month ago. The registry currently has 60 participants. We want to encourage everyone in the community to...

    Read Article

    Chondrosarcoma Resistance to Radiation Therapy: Origins and,Potential Therapeutic Solutions

    March 29th, 2023Antoine Gilbert 1, Mihaela Tudor 2,3, Juliette Montanari 1, Kevin Commenchail 1 , Diana Iulia Savu 2 ,Paul Lesueur 4,5,6 and François Chevalier 1,* Simple Summary: This review article aims in describing the origins of chondrosarcoma...

    Read Article